Acadia Pharmaceuticals
|
14.88 |
|
0.02 |
0.13% |
-12.88% |
2025-04-15 |
Agios Pharmaceuticals
|
27.64 |
|
0.12 |
0.44% |
-4.03% |
2025-04-15 |
Alnylam Pharmaceuticals
|
239.93 |
|
-0.08 |
-0.03% |
63.53% |
2025-04-15 |
Amgen
|
293.68 |
|
-0.02 |
-0.01% |
10.58% |
2025-04-15 |
Biogen
|
117.81 |
|
-1.39 |
-1.17% |
-40.16% |
2025-04-15 |
BioMarin Pharmaceutical
|
60.28 |
|
0.61 |
1.02% |
-33.66% |
2025-04-15 |
Bristol-Myers Squibb
|
50.28 |
|
-1.07 |
-2.08% |
3.50% |
2025-04-15 |
Exelixis
|
36.04 |
|
0.30 |
0.84% |
57.93% |
2025-04-15 |
Gilead Sciences
|
105.18 |
|
-1.32 |
-1.24% |
55.16% |
2025-04-15 |
Incyte
|
59.20 |
|
-0.02 |
-0.03% |
11.15% |
2025-04-15 |
Ionis Pharmaceuticals
|
28.54 |
|
-0.14 |
-0.49% |
-31.30% |
2025-04-15 |
Eli Lilly
|
763.99 |
|
10.19 |
1.35% |
2.29% |
2025-04-15 |
MacroGenics
|
1.34 |
|
0.07 |
5.51% |
-91.97% |
2025-04-15 |
Merck
|
78.76 |
|
-0.27 |
-0.34% |
-37.58% |
2025-04-15 |
Moderna
|
26.18 |
|
-0.58 |
-2.15% |
-74.80% |
2025-04-15 |
Neurocrine Biosciences
|
95.16 |
|
0.27 |
0.28% |
-28.45% |
2025-04-15 |
Novartis
|
90.19 |
|
1.45 |
1.63% |
6.10% |
2025-04-15 |
Novartis
|
110.11 |
|
0.71 |
0.65% |
16.72% |
2025-04-15 |
Pfizer
|
22.59 |
|
0.50 |
2.26% |
-12.78% |
2025-04-15 |
PTC Therapeutics
|
45.27 |
|
0.19 |
0.42% |
76.29% |
2025-04-15 |
Ultragenyx Pharmaceutical
|
34.99 |
|
0.07 |
0.20% |
-18.38% |
2025-04-15 |
Regeneron Pharmaceuticals
|
564.56 |
|
-6.05 |
-1.06% |
-36.83% |
2025-04-15 |
Sarepta Therapeutics
|
55.06 |
|
0.43 |
0.79% |
-53.06% |
2025-04-15 |
Vertex Pharmaceuticals
|
500.11 |
|
4.20 |
0.85% |
25.82% |
2025-04-15 |